...
首页> 外文期刊>The Journal of biological chemistry >Role of Lipocalin-2-Chemokine Axis in the Development of Neuropathic Pain following Peripheral Nerve Injury
【24h】

Role of Lipocalin-2-Chemokine Axis in the Development of Neuropathic Pain following Peripheral Nerve Injury

机译:脂素-2-趋化因子轴在外周神经损伤后神经疼痛发育中的作用

获取原文

摘要

Lipocalin 2 (LCN2), which is also known as 24p3 and neutrophil gelatinase-associated lipocalin (NGAL), binds small, hydrophobic ligands and interacts with cell surface receptor 24p3R to regulate diverse cellular processes. In the present study, we examined the role of LCN2 in the pathogenesis of neuropathic pain using a mouse model of spared nerve injury (SNI). Lcn2 mRNA levels were significantly increased in the dorsal horn of the spinal cord after SNI, and LCN2 protein was mainly localized in neurons of the dorsal and ventral horns. LCN2 receptor 24p3R was expressed in spinal neurons and microglia after SNI. Lcn2-deficient mice exhibited significantly less mechanical pain hypersensitivity during the early phase after SNI, and an intrathecal injection of recombinant LCN2 protein elicited mechanical pain hypersensitivity in naive animals. Lcn2 deficiency, however, did not affect acute nociceptive pain. Lcn2-deficient mice showed significantly less microglial activation and proalgesic chemokine (CCL2 and CXCL1) production in the spinal cord after SNI than wild-type mice, and recombinant LCN2 protein induced the expression of these chemokines in cultured neurons. Furthermore, the expression of LCN2 and its receptor was detected in neutrophils and macrophages in the sciatic nerve following SNI, suggesting the potential role of peripheral LCN2 in neuropathic pain. Taken together, our results indicate that LCN2 plays a critical role in the development of pain hypersensitivity following peripheral nerve injury and suggest that LCN2 mediates neuropathic pain by inducing chemokine expression and subsequent microglial activation.
机译:脂素2(LCN2),其也称为24P3和中性粒细胞明胶酶相关的脂素(NGAL),结合小,疏水配体,并与细胞表面受体24P3R相互作用以调节多种细胞过程。在本研究中,我们研究了LCN2在使用粪便神经损伤(SNI)的小鼠模型的神经病疼痛发病机制中的作用。在SNI之后,LCN2 mRNA水平在脊髓的背角中显着增加,LCN2蛋白主要是背部和腹角的神经元局部。 LCN2受体24P3R在SNI之后在脊髓神经元和微胶质细胞中表达。 LCN2缺陷小鼠在SNI的早期期间表现出显着较低的机械疼痛过敏,并且在幼稚动物中引发了重组LCN2蛋白的鞘内注射的重组疼痛过敏。然而,LCN2缺乏不影响急性伤害性疼痛。在SNI之后,LCN2缺陷小鼠在SNI之后显着减少了脊髓中的显着较低的微胶质激活和分趋化子(CCL2和CCL2和CCL2和CCL2和CCL2和CCL2和CCL2和CCL2和CCL2和CCL2和CCL2和CCL2和CCL2和CXCL1),并且重组LCN2蛋白在培养的神经元中诱导这些趋化因子的表达。此外,在SNI后坐骨神经粒细胞和巨噬细胞中检测LCN2及其受体的表达,表明外周LCN2在神经性疼痛中的潜在作用。我们的结果表明,LCN2在外周神经损伤后疼痛过敏的发展中发挥着关键作用,并表明LCN2通过诱导趋化因子表达和随后的小胶质激活来介导神经病疼痛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号